Immune Bioscience Private Limited - Company Profile

It is a business services private limited company based in Mumbai, Maharashtra, India, established in 2018.
2018 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Immune Bioscience Private Limited

Immune Bioscience Private Limited, a active private limited company, was established on 06 April 2018 in Mumbai, Maharashtra, India. Engaging in other services within the business services sector, it holds CIN: U74999MH2018PTC307669. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Shobhna Yadav (Director), Kumar Arpit (Director). Past directors included Shobhna Yadav, Sunita Vishal Patel. Its latest AGM occurred on 30 December 2020, with the balance sheet filed on 31 March 2020. It is based at Immune Bio Science Private Limited Sun Elight, Flat No. 401, Sector-18, Ulw, E, Mumbai, Maharashtra, 410206.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2018PTC307669

  • Registration Number

    307669

  • Incorporation Date

    06 April 2018

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 14 Days
  • Last Filing with ROC 31 Mar 2020
Company report

Immune Bioscience Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Immune Bioscience Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Immune Bioscience Private Limited?
Current Directors
Name Designation Appointment Date Status
Shobhna Yadav Director 04 Feb 2019 Current
Kumar Arpit Director 06 Apr 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Director 04 Feb 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Immune Bioscience.

Immune Bioscience Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Immune Bioscience revenue growth over time
Immune Bioscience profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Immune Bioscience?

Unlock access to Immune Bioscience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Immune Bioscience?

Unlock and access historical data on people associated with Immune Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Immune Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Immune Bioscience's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Immune Bioscience
Recent Activity within the Organization
  • Annual General Meeting

    The activity Immune Bioscience Private Limited last Annual general meeting of members was held on 30 Dec 2020 as per latest MCA records. was completed.

  • Balance Sheet

    Immune Bioscience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai I. was recorded as a recent event.

  • Director Appointment

    Progress on Shobhna Yadav was appointed as a Director was appointed as a Director on 04 Feb 2019 & has been associated with this company since 7 years 2 months . was documented.

  • Director Appointment

    Kumar Arpit was appointed as a Director was appointed as a Director on 06 Apr 2018 & has been associated with this company since 8 years 14 days . was recorded as a recent event.

  • Company Incorporation

    The activity Immune Bioscience Private Limited was registered on 06 Apr 2018 with Roc Mumbai I & aged 8 years 14 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Immune Bioscience Private Limited?

The CIN of Immune Bioscience Private Limited is U74999MH2018PTC307669.

Where is Immune Bioscience Private Limited headquartered?

Immune Bioscience Private Limited is headquartered at Immune Bio Science Private Limited Sun Elight, Flat No. 401, Sector-18, Ulw, E, Mumbai, Maharashtra, 410206.

When was Immune Bioscience Private Limited incorporated?

Immune Bioscience Private Limited was incorporated on 06 April 2018.

Who are the current directors of Immune Bioscience Private Limited?

The current directors of Immune Bioscience Private Limited are

What is the primary industry of Immune Bioscience Private Limited?

The primary industry of Immune Bioscience Private Limited is Business Services.

Is Immune Bioscience Private Limited a listed company?

Immune Bioscience Private Limited is unlisted.

What is the capital structure of Immune Bioscience Private Limited?

The authorized capital of Immune Bioscience Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available